Results 191 to 198 of about 8,451 (198)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Lancet, The, 2012
Hector Ortega, Ian Pavord, Eugene Bleecker   +2 more
exaly  

Mepolizumab

Drugs of the Future, 2007
null Revill, P., null Mealy, N.
openaire   +1 more source

Pharmacokinetics and pharmacodynamics of mepolizumab, an anti–interleukin 5 monoclonal antibody, in healthy Japanese male subjects

Clinical Pharmacology in Drug Development, 2016
exaly  

Mepolizumab for severe eosinophilic asthma

Expert Review of Respiratory Medicine, 2013
Douglas S Robinson
exaly  

Case study: A Combination of Mepolizumab and Omaluzimab injections for severe asthma

Journal of Asthma, 2019
exaly  

Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma

Allergy: European Journal of Allergy and Clinical Immunology
Michael Fricker
exaly  

An evaluation of mepolizumab as an add-on maintenance treatment for severe eosinophilic asthma

Expert Opinion on Biological Therapy
Ruchong Chen, Zheng Zhu
exaly  

Efficient use of mepolizumab in children: An analysis of the economically justifiable price in Colombia

Pediatric Pulmonology
Andres F Zuluaga, Jefferson Antonio Buendia   +1 more
exaly